K-pop stocks surge as China set to loosen cultural ban after 9 years

Shares in South Korea’s leading entertainment companies are rallying amid growing signs that China will likely lift its longstanding ban on Ko...

KAIST, IVI to collaborate on global vaccine research

The Korea Advanced Institute of Science & Technology (KAIST) announced on Thursday that it signed a memorandum of understanding (MOU) with the I...

Hanmi Pharm to start global clinical trials for immune-oncology drug

South Korea's Hanmi Pharmaceutical Co. announced on Tuesday that it has received approval for the phase 1 clinical trial plan of the immune-oncology...

ABL Bio gets OK for phase 1 clinical trials for immune-oncology drug

New drug development company ABL Bio Inc. announced on Thursday that it has received approval from the Ministry of Food and Drug Safety of South Kor...

NKMax to supply health functional food to Chinese company

South Korean natural killer cell drug maker NKMax Co. announced in a regulatory filing on Friday that it has signed a supply contract with China's S...

HLB submits new drug application to FDA for Rivoceranib liver cancer drug

HLB Co. announced on May 17 that it has submitted a new drug application (NDA) to the US Food and Drug Administration (FDA) for the approval of Rivo...

Hanall Biopharma invests in Interon Labs for brain disease treatments

South Korean pharmaceuticals firm Hanall Biopharma Co. is investing in Interon Laboratories, a US biotech firm that finds and develops treatments fo...

Despite liquidity crunch, 5 verticals rake in venture capital investment

The global venture capital ecosystem has been contracting since the second quarter of last year, hit by rising inflation and rate hikes. New ...

KGC creates Ginseng Museum Cafe in New York

Korea Ginseng Corporation (KGC), a wholly-owned subsidiary of KT&G Corporation, has set up its first interactive cafe in the global market where...